ReviewPharmaceuticals (Basel, Switzerland)2021

Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues.

Milo Gatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.